Company intelligence / Profile preview

Cardio Intelligence

Ownership: Private
Development stage: Commercial

Overview

Cardio Intelligence has developed and commercialized an AI-powered system that assists cardiologists by automatically analyzing electrocardiograms to detect heart diseases, particularly cardiac arrhythmias. The technology aims to improve early detection and treatment of heart conditions. The company holds at least six patents related to cardiac electrophysiology and arrhythmia detection.

Therapeutic areas: Cardiovascular
Modalities: DeviceArtificial intelligence software platform
Industry: Physiological Monitoring

Beyond the preview

Go deeper on Cardio Intelligence.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cardio Intelligence.

Explore the full profile